Where this topic shows up
Our markets on cell and gene therapy, by category.
- Pharmaceuticals · 12
Market reports
Worldwide reports first. Each covers 2024 history, a 2025 base year and forecasts to 2034.
Pharmaceuticals
AAV Gene Therapy
Worldwide · 2024–2034
View report PharmaceuticalsAllogeneic Cell Therapy
Worldwide · 2024–2034
View report PharmaceuticalsCAR-T Cell Therapy
Worldwide · 2024–2034
View report PharmaceuticalsCell and Gene Therapy CDMO
Worldwide · 2024–2034
View report PharmaceuticalsCell Therapy Manufacturing
Worldwide · 2024–2034
View report PharmaceuticalsGene Editing
Worldwide · 2024–2034
View report PharmaceuticalsGene Therapy for Hemophilia
Worldwide · 2024–2034
View report PharmaceuticalsIn Vivo CAR-T Therapy
Worldwide · 2024–2034
View report PharmaceuticalsLentiviral Vectors
Worldwide · 2024–2034
View reportKey companies
Named as key players in the most of these markets.
Charles River Laboratories5 markets here
Lonza Ltd4 markets here
Catalent3 markets here
Thermo Fisher Scientific Inc.3 markets here
BioMarin2 markets here
CRISPR Therapeutics2 markets here
CSL Behring2 markets here
Novartis AG2 markets here
Oxford Biomedica2 markets here
Vertex Pharmaceuticals2 markets here
WuXi AppTec2 markets here
AGC Biologics1 market here
All markets on this topic
Each opens the market's statistics page, with every country we cover.
Pharmaceuticals
Related topics
Need research on cell and gene therapy?
Full reports carry researched sizes, forecasts and company profiles. We also build custom studies.
Acuitas market figures are supplied with each full report. Chart data comes from the public sources named on each chart.